Novartis Raises Earnings Forecast on Strong Q3 Revenue

Novartis reported Q3 2026 revenue of $14.5B and raised its earnings forecast, signaling improved operational performance. The revision suggests stronger-than-expected demand or cost control, though specific drivers are not detailed. This is a positive signal for the company's stock and may lift sentiment in the pharma sector.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works